Clarivate Plc agrees to sell its Life Sciences & Healthcare segment to investment firm Altaris LLC for $600 million. The definitive agreement supports Clarivate’s stated focus on its Academia & Government and Intellectual Property segments, with the company directing the proceeds toward debt reduction.
Clarivate publishes its 2025 Sustainability Report, reporting a 24% year-over-year reduction in Scope 1, 2 and 3 greenhouse gas emissions. The report also notes progress across the company’s environmental, social and governance priorities.
Clarivate releases the 2026 edition of Journal Citation Reports, covering metrics for 22,643 journals across 254 categories. The edition emphasizes publisher-neutral, transparent journal evaluation for the global research community.
Clarivate names its Top 100 Global Innovators 2026, recognizing organizations leading global innovation. Based on its Derwent patent intelligence, the list highlights organizations contributing an outsized share of the world's highest-strength AI-related inventions.
